Maximus, Inc. (NYSE:MMS) Shares Acquired by Mount Yale Investment Advisors LLC

Mount Yale Investment Advisors LLC grew its stake in Maximus, Inc. (NYSE:MMS) by 12.6% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,818 shares of the health services provider’s stock after purchasing an additional 426 shares during the quarter. Mount Yale Investment Advisors LLC’s holdings in Maximus were worth $320,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. Price T Rowe Associates Inc. MD grew its position in shares of Maximus by 6.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 38,100 shares of the health services provider’s stock valued at $3,197,000 after purchasing an additional 2,322 shares during the period. LRI Investments LLC acquired a new position in Maximus during the first quarter worth about $93,000. Quadrature Capital Ltd acquired a new position in Maximus during the first quarter worth about $238,000. EntryPoint Capital LLC boosted its position in Maximus by 58.4% during the first quarter. EntryPoint Capital LLC now owns 2,678 shares of the health services provider’s stock worth $225,000 after acquiring an additional 987 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in Maximus during the first quarter worth about $2,601,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Trading Up 0.6 %

MMS stock traded up $0.59 during trading on Monday, reaching $93.11. 225,103 shares of the stock were exchanged, compared to its average volume of 334,458. The company has a current ratio of 1.53, a quick ratio of 1.53 and a debt-to-equity ratio of 0.63. The business has a 50 day moving average price of $87.17 and a 200-day moving average price of $84.14. Maximus, Inc. has a 1 year low of $72.39 and a 1 year high of $93.82. The firm has a market capitalization of $5.66 billion, a price-to-earnings ratio of 24.28 and a beta of 0.75.

Maximus (NYSE:MMS) last issued its earnings results on Wednesday, May 8th. The health services provider reported $1.57 EPS for the quarter, topping analysts’ consensus estimates of $1.31 by $0.26. Maximus had a net margin of 4.58% and a return on equity of 18.02%. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the firm earned $0.80 earnings per share. Maximus’s quarterly revenue was up 11.7% compared to the same quarter last year. On average, research analysts predict that Maximus, Inc. will post 5.79 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th will be paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date is Thursday, August 15th. Maximus’s dividend payout ratio (DPR) is presently 31.50%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.